A 5-year clinical trial was conducted on the use of atropine 0.01% eyedrops for the treatment of myopia in children. The trial was led by researchers Audrey Chia, Qing-Shu Lu, and Donald Tan and involved over 500 children with myopia. The results showed that using atropine 0.01% eyedrops was effective in reducing the progression of myopia compared to a control group. The low-dose atropine was well-tolerated with minimal side effects. The study provides evidence that low-dose atropine is a potential treatment to control the progression of childhood myopia.
A 5-year clinical trial was conducted on the use of atropine 0.01% eyedrops for the treatment of myopia in children. The trial was led by researchers Audrey Chia, Qing-Shu Lu, and Donald Tan and involved over 500 children with myopia. The results showed that using atropine 0.01% eyedrops was effective in reducing the progression of myopia compared to a control group. The low-dose atropine was well-tolerated with minimal side effects. The study provides evidence that low-dose atropine is a potential treatment to control the progression of childhood myopia.
A 5-year clinical trial was conducted on the use of atropine 0.01% eyedrops for the treatment of myopia in children. The trial was led by researchers Audrey Chia, Qing-Shu Lu, and Donald Tan and involved over 500 children with myopia. The results showed that using atropine 0.01% eyedrops was effective in reducing the progression of myopia compared to a control group. The low-dose atropine was well-tolerated with minimal side effects. The study provides evidence that low-dose atropine is a potential treatment to control the progression of childhood myopia.
Selective Laser Trabeculoplasty Versus Brimonidine Tartrate 0 2 Timolol Maleate 0 5 As Adjunct Therapy in Primary Open Angle Glaucoma A Randomized Prospective Pilot Study